<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Virtual Journal Club &#187; Am Fam Physician</title>
	<atom:link href="http://beckerinfo.net/JClub/category/am-fam-physician/feed/" rel="self" type="application/rss+xml" />
	<link>http://beckerinfo.net/JClub</link>
	<description>Division of Hospital Medicine Virtual Journal Club</description>
	<lastBuildDate>Sun, 05 Feb 2012 12:30:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Subacute management of ischemic stroke.</title>
		<link>http://beckerinfo.net/JClub/2012/01/11/subacute-management-of-ischemic-stroke/</link>
		<comments>http://beckerinfo.net/JClub/2012/01/11/subacute-management-of-ischemic-stroke/#comments</comments>
		<pubDate>Wed, 11 Jan 2012 13:02:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=dc25563f012d5862e5b90d732e1c546c</guid>
		<description><![CDATA[Subacute management of ischemic stroke.
        Am Fam Physician. 2011 Dec 15;84(12):1383...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td/></tr></table><p><b>Subacute management of ischemic stroke.</b></p>
        <p>Am Fam Physician. 2011 Dec 15;84(12):1383-8</p>
        <p>Authors:  Bernheisel CR, Schlaudecker JD, Leopold K</p>
        <p>Abstract<br/>
        Ischemic stroke is the third leading cause of death in the United States and a common reason for hospitalization. The subacute period after a stroke refers to the time when the decision to not employ thrombolytics is made up until two weeks after the stroke occurred. Family physicians are often involved in the subacute management of ischemic stroke. All patients with an ischemic stroke should be admitted to the hospital in the subacute period for cardiac and neurologic monitoring. Imaging studies, including magnetic resonance angiography, carotid artery ultrasonography, and/or echocardiography, may be indicated to determine the cause of the stroke. Evaluation for aspiration risk, including a swallowing assessment, should be performed, and nutritional, physical, occupational, and speech therapy should be initiated. Significant causes of morbidity and mortality following ischemic stroke include venous thromboembolism, pressure sores, infection, and delirium, and measures should be taken to prevent these complications. For secondary prevention of future strokes, antiplatelet therapy with aspirin should be initiated within 24 hours of ischemic stroke in all patients without contraindications, and one of several antiplatelet regimens should be continued long-term. Statin therapy should also be given in most situations. Although permissive hypertension is initially warranted, antihypertensive therapy should begin within 24 hours. Diabetes mellitus should be controlled and patients counseled about lifestyle modifications to reduce stroke risk. Rehabilitative therapy following hospitalization improves outcomes and should be considered.<br/></p><p>PMID: 22230273 [PubMed - in process]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2012/01/11/subacute-management-of-ischemic-stroke/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cirrhosis: diagnosis, management, and prevention.</title>
		<link>http://beckerinfo.net/JClub/2012/01/11/cirrhosis-diagnosis-management-and-prevention/</link>
		<comments>http://beckerinfo.net/JClub/2012/01/11/cirrhosis-diagnosis-management-and-prevention/#comments</comments>
		<pubDate>Wed, 11 Jan 2012 13:02:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=b051f78bcdfa8de8b6d5d111d9ca89e7</guid>
		<description><![CDATA[Cirrhosis: diagnosis, management, and prevention.
        Am Fam Physician. 2011 Dec 15;8...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td/></tr></table><p><b>Cirrhosis: diagnosis, management, and prevention.</b></p>
        <p>Am Fam Physician. 2011 Dec 15;84(12):1353-9</p>
        <p>Authors:  Starr SP, Raines D</p>
        <p>Abstract<br/>
        Cirrhosis is the 12th leading cause of death in the United States. It accounted for 29,165 deaths in 2007, with a mortality rate of 9.7 per 100,000 persons. Alcohol abuse and viral hepatitis are the most common causes of cirrhosis, although nonalcoholic fatty liver disease is emerging as an increasingly important cause. Primary care physicians share responsibility with specialists in managing the most common complications of the disease, screening for hepatocellular carcinoma, and preparing patients for referral to a transplant center. Patients with cirrhosis should be screened for hepatocellular carcinoma with imaging studies every six to 12 months. Causes of hepatic encephalopathy include constipation, infection, gastrointestinal bleeding, certain medications, electrolyte imbalances, and noncompliance with medical therapy. These should be sought and managed before instituting the use of lactulose or rifaximin, which is aimed at reducing serum ammonia levels. Ascites should be treated initially with salt restriction and diuresis. Patients with acute episodes of gastrointestinal bleeding should be monitored in an intensive care unit, and should have endoscopy performed within 24 hours. Physicians should also be vigilant for spontaneous bacterial peritonitis. Treating alcohol abuse, screening for viral hepatitis, and controlling risk factors for nonalcoholic fatty liver disease are mechanisms by which the primary care physician can reduce the incidence of cirrhosis.<br/></p><p>PMID: 22230269 [PubMed - in process]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2012/01/11/cirrhosis-diagnosis-management-and-prevention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evaluation of chronic diarrhea.</title>
		<link>http://beckerinfo.net/JClub/2012/01/05/evaluation-of-chronic-diarrhea/</link>
		<comments>http://beckerinfo.net/JClub/2012/01/05/evaluation-of-chronic-diarrhea/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 16:33:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=a74d7ef93857164de993c36a7f23f604</guid>
		<description><![CDATA[Evaluation of chronic diarrhea.
        Am Fam Physician. 2011 Nov 15;84(10):1119-26
    ...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td/></tr></table><p><b>Evaluation of chronic diarrhea.</b></p>
        <p>Am Fam Physician. 2011 Nov 15;84(10):1119-26</p>
        <p>Authors:  Juckett G, Trivedi R</p>
        <p>Abstract<br/>
        Chronic diarrhea, defined as a decrease in stool consistency for more than four weeks, is a common but challenging clinical scenario. It can be divided into three basic categories: watery, fatty (malabsorption), and inflammatory. Watery diarrhea may be subdivided into osmotic, secretory, and functional types. Watery diarrhea includes irritable bowel syndrome, which is the most common cause of functional diarrhea. Another example of watery diarrhea is microscopic colitis, which is a secretory diarrhea affecting older persons. Laxative-induced diarrhea is often osmotic. Malabsorptive diarrhea is characterized by excess gas, steatorrhea, or weight loss; giardiasis is a classic infectious example. Celiac disease (gluten-sensitive enteropathy) is also malabsorptive, and typically results in weight loss and iron deficiency anemia. Inflammatory diarrhea, such as ulcerative colitis or Crohn disease, is characterized by blood and pus in the stool and an elevated fecal calprotectin level. Invasive bacteria and parasites also produce inflammation. Infections caused by Clostridium difficile subsequent to antibiotic use have become increasingly common and virulent. Not all chronic diarrhea is strictly watery, malabsorptive, or inflammatory, because some categories overlap. Still, the most practical diagnostic approach is to attempt to categorize the diarrhea by type before testing and treating. This narrows the list of diagnostic possibilities and reduces unnecessary testing. Empiric therapy is justified when a specific diagnosis is strongly suspected and follow-up is available.<br/></p><p>PMID: 22085666 [PubMed - indexed for MEDLINE]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2012/01/05/evaluation-of-chronic-diarrhea/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Anaphylaxis: Recognition and Management.</title>
		<link>http://beckerinfo.net/JClub/2011/11/17/anaphylaxis-recognition-and-management/</link>
		<comments>http://beckerinfo.net/JClub/2011/11/17/anaphylaxis-recognition-and-management/#comments</comments>
		<pubDate>Thu, 17 Nov 2011 14:01:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=4ff3c4669bcfa487d59e7f7efff19042</guid>
		<description><![CDATA[Anaphylaxis: Recognition and Management.
        Am Fam Physician. 2011 Nov 15;84(10):111...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td/></tr></table><p><b>Anaphylaxis: Recognition and Management.</b></p>
        <p>Am Fam Physician. 2011 Nov 15;84(10):1111-1118</p>
        <p>Authors:  Arnold JJ, Williams PM</p>
        <p>Abstract<br/>
        Anaphylaxis is a severe, life-threatening, systemic allergic reaction that is almost always unanticipated and may lead to death by airway obstruction or vascular collapse. Anaphylaxis occurs as the result of an allergen response, usually immunoglobulin E-mediated, which leads to mast cell and basophil activation and a combination of dermatologic, respiratory, cardiovascular, gastrointestinal, and neurologic symptoms. Dermatologic and respiratory symptoms are most common, occurring in 90 and 70 percent of episodes, respectively. The three most common triggers are food, insect stings, and medications. The diagnosis of anaphylaxis is typically made when symptoms occur within one hour of exposure to a specific antigen. Confirmatory testing using serum histamine and tryptase levels is difficult, because blood samples must be drawn with strict time considerations. Allergen skin testing and in vitro assay for serum immunoglobulin E of specific allergens do not reliably predict who will develop anaphylaxis. Administration of intramuscular epinephrine at the onset of anaphylaxis, before respiratory failure or cardiovascular compromise, is essential. Histamine H1 receptor antagonists and corticosteroids may be useful adjuncts. All patients at risk of recurrent anaphylaxis should be educated about the appropriate use of prescription epinephrine autoinjectors.<br/></p><p>PMID: 22085665 [PubMed - as supplied by publisher]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/11/17/anaphylaxis-recognition-and-management/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Causes and evaluation of mildly elevated liver transaminase levels.</title>
		<link>http://beckerinfo.net/JClub/2011/11/04/causes-and-evaluation-of-mildly-elevated-liver-transaminase-levels/</link>
		<comments>http://beckerinfo.net/JClub/2011/11/04/causes-and-evaluation-of-mildly-elevated-liver-transaminase-levels/#comments</comments>
		<pubDate>Fri, 04 Nov 2011 10:31:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=4fc29c703897eddff34decca93b23c94</guid>
		<description><![CDATA[Causes and evaluation of mildly elevated liver transaminase levels.
        Am Fam Physic...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td/></tr></table><p><b>Causes and evaluation of mildly elevated liver transaminase levels.</b></p>
        <p>Am Fam Physician. 2011 Nov 1;84(9):1003-8</p>
        <p>Authors:  Oh RC, Hustead TR</p>
        <p>Abstract<br/>
        Mild elevations in levels of the liver enzymes alanine transaminase and aspartate transaminase are commonly discovered in asymptomatic patients in primary care. Evidence to guide the diagnostic workup is limited. If the history and physical examination do not suggest a cause, a stepwise evaluation should be initiated based on the prevalence of diseases that cause mild elevations in transaminase levels. The most common cause is nonalcoholic fatty liver disease, which can affect up to 30 percent of the population. Other common causes include alcoholic liver disease, medication-associated liver injury, viral hepatitis (hepatitis B and C), and hemochromatosis. Less common causes includea1-antitrypsin deficiency, autoimmune hepatitis, and Wilson disease. Extrahepatic conditions (e.g., thyroid disorders, celiac disease, hemolysis, muscle disorders) can also cause elevated liver transaminase levels. Initial testing should include a fasting lipid profile; measurement of glucose, serum iron, and ferritin; total iron-binding capacity; and hepatitis B surface antigen and hepatitis C virus antibody testing. If test results are normal, a trial of lifestyle modification with observation or further testing for less common causes is appropriate. Additional testing may include ultrasonography; measurement of a1-antitrypsin and ceruloplasmin; serum protein electrophoresis; and antinuclear antibody, smooth muscle antibody, and liver/kidney microsomal antibody type 1 testing. Referral for further evaluation and possible liver biopsy is recommended if transaminase levels remain elevated for six months or more.<br/></p><p>PMID: 22046940 [PubMed - in process]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/11/04/causes-and-evaluation-of-mildly-elevated-liver-transaminase-levels/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosis and management of osteomyelitis.</title>
		<link>http://beckerinfo.net/JClub/2011/11/04/diagnosis-and-management-of-osteomyelitis/</link>
		<comments>http://beckerinfo.net/JClub/2011/11/04/diagnosis-and-management-of-osteomyelitis/#comments</comments>
		<pubDate>Fri, 04 Nov 2011 10:31:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=83d080eb61cd9dbe96ae3f11ba00c852</guid>
		<description><![CDATA[Diagnosis and management of osteomyelitis.
        Am Fam Physician. 2011 Nov 1;84(9):102...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td/></tr></table><p><b>Diagnosis and management of osteomyelitis.</b></p>
        <p>Am Fam Physician. 2011 Nov 1;84(9):1027-33</p>
        <p>Authors:  Hatzenbuehler J, Pulling TJ</p>
        <p>Abstract<br/>
        The incidence of chronic osteomyelitis is increasing because of the prevalence of predisposing conditions such as diabetes mellitus and peripheral vascular disease. The increased availability of sensitive imaging tests, such as magnetic resonance imaging and bone scintigraphy, has improved diagnostic accuracy and the ability to characterize the infection. Plain radiography is a useful initial investigation to identify alternative diagnoses and potential complications. Direct sampling of the wound for culture and antimicrobial sensitivity is essential to target treatment. The increased incidence of methicillin-resistant Staphylococcus aureus osteomyelitis complicates antibiotic selection. Surgical debridement is usually necessary in chronic cases. The recurrence rate remains high despite surgical intervention and long-term antibiotic therapy. Acute hematogenous osteomyelitis in children typically can be treated with a four-week course of antibiotics. In adults, the duration of antibiotic treatment for chronic osteomyelitis is typically several weeks longer. In both situations, however, empiric antibiotic coverage for S. aureus is indicated.<br/></p><p>PMID: 22046943 [PubMed - in process]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/11/04/diagnosis-and-management-of-osteomyelitis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evaluation of syncope.</title>
		<link>http://beckerinfo.net/JClub/2011/09/16/evaluation-of-syncope/</link>
		<comments>http://beckerinfo.net/JClub/2011/09/16/evaluation-of-syncope/#comments</comments>
		<pubDate>Fri, 16 Sep 2011 19:58:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=64e8b3d8073c3d23eb104a5d1a339892</guid>
		<description><![CDATA[
        Evaluation of syncope.
        Am Fam Physician. 2011 Sep 15;84(6):640-50
        Authors:  Gauer RL
        Abstract
        Syncope is a transient and abrupt loss of consciousness with complete return to preexisting neurologic function. It i...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Evaluation of syncope.</b></p>
        <p>Am Fam Physician. 2011 Sep 15;84(6):640-50</p>
        <p>Authors:  Gauer RL</p>
        <p>Abstract<br>
        Syncope is a transient and abrupt loss of consciousness with complete return to preexisting neurologic function. It is classified as neurally mediated (i.e., carotid sinus hypersensitivity, situational, or vasovagal), cardiac, orthostatic, or neurogenic. Older adults are more likely to have orthostatic, carotid sinus hypersensitivity, or cardiac syn- cope, whereas younger adults are more likely to have vasovagal syncope. Common nonsyncopal syndromes with similar presentations include seizures, metabolic and psychogenic disorders, and acute intoxication. Patients presenting with syncope (other than neurally mediated and orthostatic syncope) are at increased risk of death from any cause. Useful clinical rules to assess the short-term risk of death and the need for immediate hospitalization include the San Francisco Syncope Rule and the Risk Stratification of Syncope in the Emergency Department rule. Guidelines suggest an algorithmic approach to the evaluation of syncope that begins with the history and physical examination. All patients presenting with syncope require electrocardiography, orthostatic vital signs, and QT interval monitoring. Patients with cardiovascular disease, abnormal electrocardiography, or family history of sudden death, and those presenting with unexplained syncope should be hospitalized for further diagnostic evaluation. Patients with neurally mediated or orthostatic syncope usually require no additional testing. In cases of unexplained syncope, further testing such as echocardiography, grade exercise testing, electrocardiographic monitoring, and electrophysiologic studies may be required. Although a subset of patients will have unexplained syncope despite undergoing a comprehensive evaluation, those with multiple episodes compared with an isolated event are more likely to have a serious underlying disorder.<br>
        </p><p>PMID: 21916389 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/09/16/evaluation-of-syncope/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Approach to septic arthritis.</title>
		<link>http://beckerinfo.net/JClub/2011/09/16/approach-to-septic-arthritis/</link>
		<comments>http://beckerinfo.net/JClub/2011/09/16/approach-to-septic-arthritis/#comments</comments>
		<pubDate>Fri, 16 Sep 2011 19:58:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=63b4433b04ddf99ec51592252473409e</guid>
		<description><![CDATA[
        Approach to septic arthritis.
        Am Fam Physician. 2011 Sep 15;84(6):653-60
        Authors:  Horowitz DL, Katzap E, Horowitz S, Barilla-Labarca ML
        Abstract
        Prompt diagnosis and treatment of infectious arthritis can help p...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Approach to septic arthritis.</b></p>
        <p>Am Fam Physician. 2011 Sep 15;84(6):653-60</p>
        <p>Authors:  Horowitz DL, Katzap E, Horowitz S, Barilla-Labarca ML</p>
        <p>Abstract<br>
        Prompt diagnosis and treatment of infectious arthritis can help prevent significant morbidity and mortality. The acute onset of monoarticular joint pain, erythema, heat, and immobility should raise suspicion of sepsis. Constitutional symptoms such as fever, chills, and rigors are poorly sensitive for septic arthritis. In the absence of peripheral leukopenia or prosthetic joint replacement, synovial fluid white blood cell count in patients with septic arthritis is usually greater than 50,000 per mm3. Isolation of the causative agent through synovial fluid culture is not only definitive but also essential before selecting antibiotic therapy. Synovial fluid analysis is also useful to help distinguish crystal arthropathy from infectious arthritis, although the two occasionally coexist. Almost any microorganism can be pathogenic in septic arthritis; however, septic arthritis is caused by nongonococcal pathogens (most commonly Staphylococcus species) in more than 80 percent of patients. Gram stain results should guide initial antibiotic choice. Vancomycin can be used for gram-positive cocci, ceftriaxone for gram-negative cocci, and ceftazidime for gram-negative rods. If the Gram stain is negative, but there is strong clinical suspicion for bacterial arthritis, treatment with vancomycin plus ceftazidime or an aminoglycoside is appropriate. Evacuation of purulent material with arthrocentesis or surgical methods is necessary. Special consideration should be given to patients with prosthetic joint infection. In this population, the intraarticular cutoff values for infection may be as low as 1,100 white blood cells per mm3 with a neutrophil differential of greater than 64 percent.<br>
        </p><p>PMID: 21916390 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/09/16/approach-to-septic-arthritis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The geriatric assessment.</title>
		<link>http://beckerinfo.net/JClub/2011/09/07/the-geriatric-assessment/</link>
		<comments>http://beckerinfo.net/JClub/2011/09/07/the-geriatric-assessment/#comments</comments>
		<pubDate>Thu, 08 Sep 2011 01:16:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=c265d06bf1380fc8520f231bf8128b3a</guid>
		<description><![CDATA[
        The geriatric assessment.
        Am Fam Physician. 2011 Jan 1;83(1):48-56
        Authors:  Elsawy B, Higgins KE
        Abstract
        The geriatric assessment is a multidimensional, multidisciplinary assessment designed to evaluate an old...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>The geriatric assessment.</b></p>
        <p>Am Fam Physician. 2011 Jan 1;83(1):48-56</p>
        <p>Authors:  Elsawy B, Higgins KE</p>
        <p>Abstract<br>
        The geriatric assessment is a multidimensional, multidisciplinary assessment designed to evaluate an older person's functional ability, physical health, cognition and mental health, and socioenvironmental circumstances. It is usually initiated when the physician identifies a potential problem. Specific elements of physical health that are evaluated include nutrition, vision, hearing, fecal and urinary continence, and balance. The geriatric assessment aids in the diagnosis of medical conditions; development of treatment and follow-up plans; coordination of management of care; and evaluation of long-term care needs and optimal placement. The geriatric assessment differs from a standard medical evaluation by including nonmedical domains; by emphasizing functional capacity and quality of life; and, often, by incorporating a multidisciplinary team. It usually yields a more complete and relevant list of medical problems, functional problems, and psychosocial issues. Well-validated tools and survey instruments for evaluating activities of daily living, hearing, fecal and urinary continence, balance, and cognition are an important part of the geriatric assessment. Because of the demands of a busy clinical practice, most geriatric assessments tend to be less comprehensive and more problem-directed. When multiple concerns are presented, the use of a "rolling" assessment over several visits should be considered. Academy of Family Physicians.<br>
        </p><p>PMID: 21888128 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/09/07/the-geriatric-assessment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Atrial fibrillation: diagnosis and treatment.</title>
		<link>http://beckerinfo.net/JClub/2011/09/07/atrial-fibrillation-diagnosis-and-treatment/</link>
		<comments>http://beckerinfo.net/JClub/2011/09/07/atrial-fibrillation-diagnosis-and-treatment/#comments</comments>
		<pubDate>Thu, 08 Sep 2011 01:15:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=31f3cfc38c28c9aa2bccef883616aa99</guid>
		<description><![CDATA[
        Atrial fibrillation: diagnosis and treatment.
        Am Fam Physician. 2011 Jan 1;83(1):61-8
        Authors:  Gutierrez C, Blanchard DG
        Abstract
        Atrial fibrillation is the most common cardiac arrhythmia. It impairs cardiac fu...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Atrial fibrillation: diagnosis and treatment.</b></p>
        <p>Am Fam Physician. 2011 Jan 1;83(1):61-8</p>
        <p>Authors:  Gutierrez C, Blanchard DG</p>
        <p>Abstract<br>
        Atrial fibrillation is the most common cardiac arrhythmia. It impairs cardiac function and increases the risk of stroke. The incidence of atrial fibrillation increases with age. Key treatment issues include deciding when to restore normal sinus rhythm, when to control rate only, and how to prevent thromboembolism. Rate control is the preferred management option in most patients. Rhythm control is an option for patients in whom rate control cannot be achieved or who have persistent symptoms despite rate control. The current recommendation for strict rate control is a resting heart rate of less than 80 beats per minute. However, one study has shown that more lenient rate control of less than 110 beats per minute while at rest was not inferior to strict rate control in preventing cardiac death, heart failure, stroke, and life-threatening arrhythmias. Anticoagulation therapy is needed with rate control and rhythm control to prevent stroke. Warfarin is superior to aspirin and clopidogrel in preventing stroke despite its narrow therapeutic range and increased risk of bleeding. Tools that predict the risk of stroke (e.g., CHADS2) and the risk of bleeding (e.g., Outpatient Bleeding Risk Index) are helpful in making decisions about anticoagulation therapy. Surgical options for atrial fibrillation include disruption of abnormal conduction pathways in the atria, and obliteration of the left atrial appendage. Catheter ablation is an option for restoring normal sinus rhythm in patients with paroxysmal atrial fibrillation and normal left atrial size. Referral to a cardiologist is warranted in patients who have complex cardiac disease; who are symptomatic on or unable to tolerate pharmacologic rate control; or who may be candidates for ablation or surgical interventions.<br>
        </p><p>PMID: 21888129 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/09/07/atrial-fibrillation-diagnosis-and-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosis and treatment of acute pyelonephritis in women.</title>
		<link>http://beckerinfo.net/JClub/2011/09/07/diagnosis-and-treatment-of-acute-pyelonephritis-in-women/</link>
		<comments>http://beckerinfo.net/JClub/2011/09/07/diagnosis-and-treatment-of-acute-pyelonephritis-in-women/#comments</comments>
		<pubDate>Thu, 08 Sep 2011 01:15:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=ae29954f604d4caa28932afb59a98aa1</guid>
		<description><![CDATA[
        Diagnosis and treatment of acute pyelonephritis in women.
        Am Fam Physician. 2011 Sep 1;84(5):519-26
        Authors:  Colgan R, Williams M, Johnson JR
        Abstract
        Acute pyelonephritis is a common bacterial infection of the...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Diagnosis and treatment of acute pyelonephritis in women.</b></p>
        <p>Am Fam Physician. 2011 Sep 1;84(5):519-26</p>
        <p>Authors:  Colgan R, Williams M, Johnson JR</p>
        <p>Abstract<br>
        Acute pyelonephritis is a common bacterial infection of the renal pelvis and kidney most often seen in young adult women. History and physical examination are the most useful tools for diagnosis. Most patients have fever, although it may be absent early in the illness. Flank pain is nearly universal, and its absence should raise suspicion of an alternative diagnosis. A positive urinalysis confirms the diagnosis in patients with a compatible history and physical examination. Urine culture should be obtained in all patients to guide antibiotic therapy if the patient does not respond to initial empiric antibiotic regimens. Escherichia coli is the most common pathogen in acute pyelonephritis, and in the past decade, there has been an increasing rate of E. coli resistance to extended-spectrum beta-lactam antibiotics. Imaging, usually with contrast-enhanced computed tomography, is not necessary unless there is no improvement in the patient's symptoms or if there is symptom recurrence after initial improvement. Outpatient treatment is appropriate for most patients. Inpatient therapy is recommended for patients who have severe illness or in whom a complication is suspected. Practice guidelines recommend oral fluoroquinolones as initial outpatient therapy if the rate of fluoroquinolone resistance in the community is 10 percent or less. If the resistance rate exceeds 10 percent, an initial intravenous dose of ceftriaxone or gentami- cin should be given, followed by an oral fluoroquinolone regimen. Oral beta-lactam antibiotics and trimethoprim/sulfamethoxazole are generally inappropriate for outpatient therapy because of high resistance rates. Several antibiotic regimens can be used for inpatient treatment, including fluoroquinolones, aminoglycosides, and cephalosporins.<br>
        </p><p>PMID: 21888302 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/09/07/diagnosis-and-treatment-of-acute-pyelonephritis-in-women/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Evaluation and management of orthostatic hypotension.</title>
		<link>http://beckerinfo.net/JClub/2011/09/07/evaluation-and-management-of-orthostatic-hypotension/</link>
		<comments>http://beckerinfo.net/JClub/2011/09/07/evaluation-and-management-of-orthostatic-hypotension/#comments</comments>
		<pubDate>Thu, 08 Sep 2011 01:15:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=7ce721b6356069358d583579b2a481e3</guid>
		<description><![CDATA[
        Evaluation and management of orthostatic hypotension.
        Am Fam Physician. 2011 Sep 1;84(5):527-36
        Authors:  Lanier JB, Mote MB, Clay EC
        Abstract
        Orthostatic hypotension is defined as a decrease in systolic blood p...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Evaluation and management of orthostatic hypotension.</b></p>
        <p>Am Fam Physician. 2011 Sep 1;84(5):527-36</p>
        <p>Authors:  Lanier JB, Mote MB, Clay EC</p>
        <p>Abstract<br>
        Orthostatic hypotension is defined as a decrease in systolic blood pressure of 20 mm Hg or a decrease in diastolic blood pressure of 10 mm Hg within three minutes of standing when compared with blood pressure from the sitting or supine position. It results from an inadequate physiologic response to postural changes in blood pressure. Orthostatic hypotension may be acute or chronic, as well as symptomatic or asymptomatic. Common symptoms include dizziness, lightheadedness, blurred vision, weakness, fatigue, nausea, palpitations, and headache. Less common symptoms include syncope, dyspnea, chest pain, and neck and shoulder pain. Causes include dehydration or blood loss; disorders of the neurologic, cardiovascular, or endocrine systems; and several classes of medications. Evaluation of suspected orthostatic hypotension begins by identifying reversible causes and underlying associated medical conditions. Head-up tilt-table testing can aid in confirming a diagnosis of suspected orthostatic hypotension when standard orthostatic vital signs are nondiagnostic; it also can aid in assessing treatment response in patients with an autonomic disorder. Goals of treatment involve improving hypotension without excessive supine hypertension, relieving orthostatic symptoms, and improving standing time. Treatment includes correcting reversible causes and discontinuing responsible medications, when possible. Nonpharmacologic treatment should be offered to all patients. For patients who do not respond adequately to nonpharmacologic treatment, fludrocortisone, midodrine, and pyridostigmine are pharmacologic therapies proven to be beneficial.<br>
        </p><p>PMID: 21888303 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/09/07/evaluation-and-management-of-orthostatic-hypotension/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosis and management of community-acquired pneumonia in adults.</title>
		<link>http://beckerinfo.net/JClub/2011/08/31/diagnosis-and-management-of-community-acquired-pneumonia-in-adults/</link>
		<comments>http://beckerinfo.net/JClub/2011/08/31/diagnosis-and-management-of-community-acquired-pneumonia-in-adults/#comments</comments>
		<pubDate>Wed, 31 Aug 2011 21:39:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=a202dea17d7b49fd41832d90a3b47e4e</guid>
		<description><![CDATA[
        Diagnosis and management of community-acquired pneumonia in adults.
        Am Fam Physician. 2011 Jun 1;83(11):1299-306
        Authors:  Watkins RR, Lemonovich TL
        Abstract
        Community-acquired pneumonia is diagnosed by clinical...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Diagnosis and management of community-acquired pneumonia in adults.</b></p>
        <p>Am Fam Physician. 2011 Jun 1;83(11):1299-306</p>
        <p>Authors:  Watkins RR, Lemonovich TL</p>
        <p>Abstract<br>
        Community-acquired pneumonia is diagnosed by clinical features (e.g., cough, fever, pleuritic chest pain) and by lung imaging, usually an infiltrate seen on chest radiography. Initial evaluation should determine the need for hospitalization versus outpatient management using validated mortality or severity prediction scores. Selected diagnostic laboratory testing, such as sputum and blood cultures, is indicated for inpatients with severe illness but is rarely useful for outpatients. Initial outpatient therapy should include a macrolide or doxycycline. For outpatients with comorbidities or who have used antibiotics within the previous three months, a respiratory fluoroquinolone (levofloxacin, gemifloxacin, or moxifloxacin), or an oral beta-lactam antibiotic plus a macrolide should be used. Inpatients not admitted to an intensive care unit should receive a respiratory fluoroquinolone, or a beta-lactam antibiotic plus a macrolide. Patients with severe community-acquired pneumonia or who are admitted to the intensive care unit should be treated with a beta-lactam antibiotic, plus azithromycin or a respiratory fluoroquinolone. Those with risk factors for Pseudomonas should be treated with a beta-lactam antibiotic (piperacillin/tazobactam, imipenem/cilastatin, meropenem, doripenem, or cefepime), plus an aminoglycoside and azithromycin or an antipseudomonal fluoroquinolone (levofloxacin or ciprofloxacin). Those with risk factors for methicillin-resistant Staphylococcus aureus should be given vancomycin or linezolid. Hospitalized patients may be switched from intravenous to oral antibiotics after they have clinical improvement and are able to tolerate oral medications, typically in the first three days. Adherence to the Infectious Diseases Society of America/American Thoracic Society guidelines for the management of community-acquired pneumonia has been shown to improve patient outcomes. Physicians should promote pneumococcal and influenza vaccination as a means to prevent community-acquired pneumonia and pneumococcal bacteremia.<br>
        </p><p>PMID: 21661712 [PubMed - indexed for MEDLINE]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/08/31/diagnosis-and-management-of-community-acquired-pneumonia-in-adults/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnostic approach to chronic constipation in adults.</title>
		<link>http://beckerinfo.net/JClub/2011/08/17/diagnostic-approach-to-chronic-constipation-in-adults/</link>
		<comments>http://beckerinfo.net/JClub/2011/08/17/diagnostic-approach-to-chronic-constipation-in-adults/#comments</comments>
		<pubDate>Wed, 17 Aug 2011 14:26:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=a82ea4081d808c1f963c07affebc6313</guid>
		<description><![CDATA[
        Diagnostic approach to chronic constipation in adults.
        Am Fam Physician. 2011 Aug 1;84(3):299-306
        Authors:  Jamshed N, Lee ZE, Olden KW
        Constipation is traditionally defined as three or fewer bowel movements per week. R...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Diagnostic approach to chronic constipation in adults.</b></p>
        <p>Am Fam Physician. 2011 Aug 1;84(3):299-306</p>
        <p>Authors:  Jamshed N, Lee ZE, Olden KW</p>
        <p>Constipation is traditionally defined as three or fewer bowel movements per week. Risk factors for constipation include female sex, older age, inactivity, low caloric intake, low-fiber diet, low income, low educational level, and taking a large number of medications. Chronic constipation is classified as functional (primary) or secondary. Functional constipation can be divided into normal transit, slow transit, or outlet constipation. Possible causes of secondary chronic constipation include medication use, as well as medical conditions, such as hypothyroidism or irritable bowel syndrome. Frail older patients may present with nonspecific symptoms of constipation, such as delirium, anorexia, and functional decline. The evaluation of constipation includes a history and physical examination to rule out alarm signs and symptoms. These include evidence of bleeding, unintended weight loss, iron deficiency anemia, acute onset constipation in older patients, and rectal prolapse. Patients with one or more alarm signs or symptoms require prompt evaluation. Referral to a subspecialist for additional evaluation and diagnostic testing may be warranted.</p>
        <p>PMID: 21842777 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/08/17/diagnostic-approach-to-chronic-constipation-in-adults/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of acute asthma exacerbations.</title>
		<link>http://beckerinfo.net/JClub/2011/07/20/management-of-acute-asthma-exacerbations/</link>
		<comments>http://beckerinfo.net/JClub/2011/07/20/management-of-acute-asthma-exacerbations/#comments</comments>
		<pubDate>Thu, 21 Jul 2011 02:45:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Am Fam Physician]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[
        Management of acute asthma exacerbations.
        Am Fam Physician. 2011 Jul 1;84(1):40-7
        Authors:  Pollart SM, Compton RM, Elward KS
        Asthma exacerbations can be classified as mild, moderate, severe, or life threatening. Criter...]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"></td></tr></table>
        <p><b>Management of acute asthma exacerbations.</b></p>
        <p>Am Fam Physician. 2011 Jul 1;84(1):40-7</p>
        <p>Authors:  Pollart SM, Compton RM, Elward KS</p>
        <p>Asthma exacerbations can be classified as mild, moderate, severe, or life threatening. Criteria for exacerbation severity are based on symptoms and physical examination parameters, as well as lung function and oxygen saturation. In patients with a peak expiratory flow of 50 to 79 percent of their personal best, up to two treatments of two to six inhalations of short-acting beta2 agonists 20 minutes apart followed by a reassessment of peak expiratory flow and symptoms may be safely employed at home. Administration using a hand-held metered-dose inhaler with a spacer device is at least equivalent to nebulized beta2 agonist therapy in children and adults. In the ambulatory and emergency department settings, the goals of treatment are correction of severe hypoxemia, rapid reversal of airflow obstruction, and reduction of the risk of relapse. Multiple doses of inhaled anticholinergic medication combined with beta2 agonists improve lung function and decrease hospitalization in school-age children with severe asthma exacerbations. Intravenous magnesium sulfate has been shown to significantly increase lung function and decrease the necessity of hospitalization in children. The administration of systemic corticosteroids within one hour of emergency department presentation decreases the need for hospitalization, with the most pronounced effect in patients with severe exacerbations. Airway inflammation can persist for days to weeks after an acute attack; therefore, more intensive treatment should be continued after discharge until symptoms and peak expiratory flow return to baseline.</p>
        <p>PMID: 21766754 [PubMed - in process]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2011/07/20/management-of-acute-asthma-exacerbations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

